Lynn Butler

The primary focus of the Translational Vascular Research group is the study of endothelial cells that line the inside of all blood vessels. These cells have many functions, such as providing an anti-thrombotic surface to prevent blood clotting and controlling leukocyte recruitment to tissue during inflammation. Our research is based around the identification of genes that are highly specifically expressed in endothelial cells (compared to other cell types) and the role of these genes in vascular function. Through this work, we identify potential plasma biomarker candidates for the clinical assessment of vascular health and risk stratification, diagnosis and prognosis of diseases of the cardiovascular system, such as venous and arterial thrombosis and COVID-19 complications.

Education and postdoctoral experience

1998-01      Medical Science (B.Med.Sc Hons), Class 2.1. University of Birmingham, UK.                                        

2001-05      Ph.D. Medicine. University of Birmingham, UK.                                        

2008-11       Cancer Research UK Fellow, University of Birmingham, UK

2005-08      British Heart Foundation Fellow, University of Birmingham, UK                      

Academic positions

2018-          Associate Professor: Dept. of Clinical Medicine, The Arctic University of Norway

                    Senior Researcher: Dept of Molecular Medicine and Surgery, Karolinska Institute, Sweden

                    Affiliation: Associated Investigator EMBL Centre for Molecular Medicine, Norway

2014-17      Research Group Leader: Clinical Chemistry, University Medical Centre Hamburg, Germany 

                    Senior Researcher: Dept. Molecular Medicine and Surgery, Karolinska Institute

2011-14      Assistant Professor: Dept. of Medicine, Karolinska Institute, Stockholm

Leader of the Translational Vascular Research Group

Profile at ORCID